Unveiling the Potential of Cannabinoids in Multiple Sclerosis and the Dawn of Nano-Cannabinoid Medicine
Roua A. Nouh | Ahmed Kamal | Oluwaseyi Oyewole | Walaa A. Abbas | Bishoy Abib | Abdelrouf Omar | Somaia T. Mansour | Anwar Abdelnaser | Roua A | Walaa A
Clinical studies on the use of cannabinoids for the management of multiple sclerosis. Treatment of Multiple Sclerosis: A Review. Multiple Sclerosis. Cannabis Cannabinoid. Delta-9-THC in the treatment of spasticity associated with multiple sclerosis.
Tags:
- Endocannabinoid system
- Cannabinoid
- Multiple sclerosis
- Nanoparticles for drug delivery to the brain
- Nabilone
- Cannabidiol
- Cannabinoid receptor
- Blood–brain barrier
- Glatiramer acetate
- Management of multiple sclerosis
- Tetrahydrocannabinol
- Anandamide
- Neurotransmitter
- Cannabinoid receptor 2
- Interferon beta-1b
- Biology
- Medical specialties
- Clinical medicine